A Randomized, Controlled, Multicenter Clinical Trial Comparing Pemetrexed/Cisplatin and Gemcitabine/Cisplatin as First-line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer

A Randomized, Controlled, Multicenter Clinical Trial Comparing Pemetrexed/Cisplatin and Gemcitabine/Cisplatin as First-line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer

Background and objective Platinum-based doublet chemotherapy is still the standard first-line treatment for non-small cell lung cancer (NSCLC). Previous studies have demonstrated that pemetrexed combined with platinum had promising efficacy and safety profile in NSCLC, especially in patients with no...

Full description

Bibliographic Details
Main Authors: Yan HUANG, Yunpeng LIU, Jianying ZHOU, Nong XU, Baolan LI, Gang WU, Jian FANG, Kai LI, Xiaoqing LIU, Wei LIU, You LU, Mengzhao WANG, Wenchao LIU, Houjie LIANG, Yiping ZHANG, Cheng HUANG, Shunjin WANG, Yajie WANG, Shiying YU, Jianhua CHANG, Zhehai WANG, Zhihuang HU, Li ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2012-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasm
Pemetrexed
Gemcitabine
Cisplatin
Chemotherapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2012.10.03

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2012.10.03

Similar Items